Cargando…

Molecular characterization and cell type composition deconvolution of fibrosis in NAFLD

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of liver disease worldwide. In adults with NAFLD, fibrosis can develop and progress to liver cirrhosis and liver failure. However, the underlying molecular mechanisms of fibrosis progression are not fully understood. Using total RNA-...

Descripción completa

Detalles Bibliográficos
Autores principales: Pantano, Lorena, Agyapong, George, Shen, Yang, Zhuo, Zhu, Fernandez-Albert, Francesc, Rust, Werner, Knebel, Dagmar, Hill, Jon, Boustany-Kari, Carine M., Doerner, Julia F., Rippmann, Jörg F., Chung, Raymond T., Ho Sui, Shannan J., Simon, Eric, Corey, Kathleen E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8433177/
https://www.ncbi.nlm.nih.gov/pubmed/34508113
http://dx.doi.org/10.1038/s41598-021-96966-5
_version_ 1783751322984513536
author Pantano, Lorena
Agyapong, George
Shen, Yang
Zhuo, Zhu
Fernandez-Albert, Francesc
Rust, Werner
Knebel, Dagmar
Hill, Jon
Boustany-Kari, Carine M.
Doerner, Julia F.
Rippmann, Jörg F.
Chung, Raymond T.
Ho Sui, Shannan J.
Simon, Eric
Corey, Kathleen E.
author_facet Pantano, Lorena
Agyapong, George
Shen, Yang
Zhuo, Zhu
Fernandez-Albert, Francesc
Rust, Werner
Knebel, Dagmar
Hill, Jon
Boustany-Kari, Carine M.
Doerner, Julia F.
Rippmann, Jörg F.
Chung, Raymond T.
Ho Sui, Shannan J.
Simon, Eric
Corey, Kathleen E.
author_sort Pantano, Lorena
collection PubMed
description Non-alcoholic fatty liver disease (NAFLD) is the most common cause of liver disease worldwide. In adults with NAFLD, fibrosis can develop and progress to liver cirrhosis and liver failure. However, the underlying molecular mechanisms of fibrosis progression are not fully understood. Using total RNA-Seq, we investigated the molecular mechanisms of NAFLD and fibrosis. We sequenced liver tissue from 143 adults across the full spectrum of fibrosis stage including those with stage 4 fibrosis (cirrhosis). We identified gene expression clusters that strongly correlate with fibrosis stage including four genes that have been found consistently across previously published transcriptomic studies on NASH i.e. COL1A2, EFEMP2, FBLN5 and THBS2. Using cell type deconvolution, we estimated the loss of hepatocytes versus gain of hepatic stellate cells, macrophages and cholangiocytes with advancing fibrosis stage. Hepatocyte-specific functional analysis indicated increase of pro-apoptotic pathways and markers of bipotent hepatocyte/cholangiocyte precursors. Regression modelling was used to derive predictors of fibrosis stage. This study elucidated molecular and cell composition changes associated with increasing fibrosis stage in NAFLD and defined informative gene signatures for the disease.
format Online
Article
Text
id pubmed-8433177
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-84331772021-09-13 Molecular characterization and cell type composition deconvolution of fibrosis in NAFLD Pantano, Lorena Agyapong, George Shen, Yang Zhuo, Zhu Fernandez-Albert, Francesc Rust, Werner Knebel, Dagmar Hill, Jon Boustany-Kari, Carine M. Doerner, Julia F. Rippmann, Jörg F. Chung, Raymond T. Ho Sui, Shannan J. Simon, Eric Corey, Kathleen E. Sci Rep Article Non-alcoholic fatty liver disease (NAFLD) is the most common cause of liver disease worldwide. In adults with NAFLD, fibrosis can develop and progress to liver cirrhosis and liver failure. However, the underlying molecular mechanisms of fibrosis progression are not fully understood. Using total RNA-Seq, we investigated the molecular mechanisms of NAFLD and fibrosis. We sequenced liver tissue from 143 adults across the full spectrum of fibrosis stage including those with stage 4 fibrosis (cirrhosis). We identified gene expression clusters that strongly correlate with fibrosis stage including four genes that have been found consistently across previously published transcriptomic studies on NASH i.e. COL1A2, EFEMP2, FBLN5 and THBS2. Using cell type deconvolution, we estimated the loss of hepatocytes versus gain of hepatic stellate cells, macrophages and cholangiocytes with advancing fibrosis stage. Hepatocyte-specific functional analysis indicated increase of pro-apoptotic pathways and markers of bipotent hepatocyte/cholangiocyte precursors. Regression modelling was used to derive predictors of fibrosis stage. This study elucidated molecular and cell composition changes associated with increasing fibrosis stage in NAFLD and defined informative gene signatures for the disease. Nature Publishing Group UK 2021-09-10 /pmc/articles/PMC8433177/ /pubmed/34508113 http://dx.doi.org/10.1038/s41598-021-96966-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Pantano, Lorena
Agyapong, George
Shen, Yang
Zhuo, Zhu
Fernandez-Albert, Francesc
Rust, Werner
Knebel, Dagmar
Hill, Jon
Boustany-Kari, Carine M.
Doerner, Julia F.
Rippmann, Jörg F.
Chung, Raymond T.
Ho Sui, Shannan J.
Simon, Eric
Corey, Kathleen E.
Molecular characterization and cell type composition deconvolution of fibrosis in NAFLD
title Molecular characterization and cell type composition deconvolution of fibrosis in NAFLD
title_full Molecular characterization and cell type composition deconvolution of fibrosis in NAFLD
title_fullStr Molecular characterization and cell type composition deconvolution of fibrosis in NAFLD
title_full_unstemmed Molecular characterization and cell type composition deconvolution of fibrosis in NAFLD
title_short Molecular characterization and cell type composition deconvolution of fibrosis in NAFLD
title_sort molecular characterization and cell type composition deconvolution of fibrosis in nafld
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8433177/
https://www.ncbi.nlm.nih.gov/pubmed/34508113
http://dx.doi.org/10.1038/s41598-021-96966-5
work_keys_str_mv AT pantanolorena molecularcharacterizationandcelltypecompositiondeconvolutionoffibrosisinnafld
AT agyaponggeorge molecularcharacterizationandcelltypecompositiondeconvolutionoffibrosisinnafld
AT shenyang molecularcharacterizationandcelltypecompositiondeconvolutionoffibrosisinnafld
AT zhuozhu molecularcharacterizationandcelltypecompositiondeconvolutionoffibrosisinnafld
AT fernandezalbertfrancesc molecularcharacterizationandcelltypecompositiondeconvolutionoffibrosisinnafld
AT rustwerner molecularcharacterizationandcelltypecompositiondeconvolutionoffibrosisinnafld
AT knebeldagmar molecularcharacterizationandcelltypecompositiondeconvolutionoffibrosisinnafld
AT hilljon molecularcharacterizationandcelltypecompositiondeconvolutionoffibrosisinnafld
AT boustanykaricarinem molecularcharacterizationandcelltypecompositiondeconvolutionoffibrosisinnafld
AT doernerjuliaf molecularcharacterizationandcelltypecompositiondeconvolutionoffibrosisinnafld
AT rippmannjorgf molecularcharacterizationandcelltypecompositiondeconvolutionoffibrosisinnafld
AT chungraymondt molecularcharacterizationandcelltypecompositiondeconvolutionoffibrosisinnafld
AT hosuishannanj molecularcharacterizationandcelltypecompositiondeconvolutionoffibrosisinnafld
AT simoneric molecularcharacterizationandcelltypecompositiondeconvolutionoffibrosisinnafld
AT coreykathleene molecularcharacterizationandcelltypecompositiondeconvolutionoffibrosisinnafld